News

Receiving of a GMP certificate – strategically important event for the company LUMIER PHARMA LLC

11 September 2012
August 27, 2012 the State Service of Ukraine for Medicinal Products issued a certificate of GMP compliance to LUMIER PHARMA LLC.

Themutual meeting of LUMIER PHARMA LLC and F.Hoffmann-La Roche Ltd with the representatives of the All-Communities Advisory Council on Access to Treatment in Ukraine (UCAB )

14 March 2012
On March 14, 2012, the mutual meeting with the representatives of the All-Communities Advisory Council on Access to Treatment in Ukraine was held. The main objective of the meeting was to introduce to the meeting participants the medicine PEGFERON, PEG-interferon alpha 2, manufactured by LUMIER PHARMA LLC and the F.Hoffmann-La Roche Ltd Company.

Next stage of cooperation between LUMIER PHARMA LLC and F.Hoffmann-La Roche Ltd

7 February 2012
At the beginning of 2012, LUMIER PHARMA LLC registered two medications developed by the F.Hoffmann-La Roche Ltd Company that will be produced in Ukraine in the framework of a mutual project with LUMIER PHARMA LLC.

Oktapharma specialists performed the audit of the LUMIER PHARMA LLC

28 July 2011
In June 2011, the specialists of the world’s leading manufacturer of high-quality plasma medicines, the Octapharma Company, performed external audit of the LUMIER PHARMA LLC.

F.Hoffmann-La Roche Ltd performed the inspection of LUMIER PHARMA LLC production capacity and internal processes

25 March 2011
The world’s leading manufacturer of pharmaceuticals, the F.Hoffmann-La Roche Ltd Company, conducted an examination and inspection of LUMIER PHARMA LLC production capacity and internal processes to verify the successful fulfillment of the final stage of biotechnological medicines production in Ukraine.

LUMIER PHARMA LLC and F.Hoffmann-La Roche Ltd social project on the production of PEGFERON, PEG-interferon alpha-2a in Ukraine

15 February 2010
Commenced in March, 2010 was the first stage of work on the mutual social project of the world’s leading manufacturer of pharmaceuticals, the F.Hoffmann-La Roche Ltd Company, and the domestic company LUMIER PHARMA LLC.
Pages: Первая Предыдущая 1 2 3 4